Enliven Therapeutics (NASDAQ:ELVN) Price Target Raised to $40.00
Enliven Therapeutics (NASDAQ:ELVN – Get Free Report) had its target price boosted by investment analysts at HC Wainwright from $39.00 to $40.00 in a research report issued on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s price target points to a potential upside of 137.25% from the stock’s current […]
Enliven Therapeutics (NASDAQ:ELVN – Get Free Report) had its target price boosted by investment analysts at HC Wainwright from $39.00 to $40.00 in a research report issued on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s price target points to a potential upside of 137.25% from the stock’s current […]
